Front. Cell Dev. Biol. Frontiers in Cell and Developmental Biology Front. Cell Dev. Biol. 2296-634X Frontiers Media S.A. 1788573 10.3389/fcell.2026.1788573 Retraction Retraction: MiR-221/222 ameliorates deoxynivalenol-induced apoptosis and proliferation inhibition in intestinal epithelial cells by targeting PTEN Frontiers Editorial Office 10.3389/fcell.2026.1788573 Frontiers Editorial Office * *Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org 21 01 2026 2026 14 1788573 15 01 2026 15 01 2026 Copyright © 2026 Frontiers Editorial Office. 2026 Frontiers Editorial Office https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. A Retraction of the Original Research Article MiR-221/222 ameliorates deoxynivalenol-induced apoptosis and proliferation inhibition in intestinal epithelial cells by targeting PTEN by Hou L, Tong X, Lin S, Yu M, Ye W-C and Xie M (2021). Front. Cell Dev. Biol. 9:652939. doi: 10.3389/fcell.2021.652939 section-at-acceptance Cell Death and Survival

The journal retracts the 19 May 2021 article cited above.

Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide the raw data or a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. Given the concerns about the validity of the data, and the lack of raw data, the editors no longer have confidence in the findings presented in the article.

This retraction was approved by the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction and had a chance to respond. This communication is recorded by the publisher.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland